Tag: GLP-1 drugs

Ozempic, Profits, and the $50 Billion Question: What Are We Really Solving?

Reading Time: 4 minutesRecently, AstraZeneca announced it would invest $50 billion in drug research and manufacturing over the next five years. At first glance, that sounds like great news—more innovation, better treatment options, and improved access to healthcare. But let’s ask the deeper Read more…

What Are GLP-1 Drugs Like Ozempic and Why Are They So Popular?

Reading Time: 4 minutesOver the past few years, a new class of drugs has gained enormous attention: GLP-1 receptor agonists, commonly known by brand names like Ozempic, Wegovy, and Mounjaro. Originally designed to help people manage Type 2 diabetes, these medications are now Read more…

Contact articles@usabusinessradio.net
for more information on articles on this site. bmuyco@usabusinessradio.net for all other information.

The author of the best selling finance book of all time celebrates its 20th anniversary in a series of interviews with Kevin Price on the Price of Business.

Kevin Price, Editor at Large of Daily Business Journal and host of the nationally syndicated Price of Business show writes frequently at Quora about issues ranging from politics to personality types. His favorite answers are also found at USA Business Radio.

Tag: GLP-1 drugs

Ozempic, Profits, and the $50 Billion Question: What Are We Really Solving?

What Are GLP-1 Drugs Like Ozempic and Why Are They So Popular?

Celebrating 25 Years of the Price of Business Show

VIDEO: This Week’s Best of our Network

USABR: Nationally Syndicated Radio Distribution

Contact

Recent Stories in DBJ

Kevin Price’s “New Rich” Book Ready for Pre-order for 99 cents!

The Price of Business Visits with Robert Kiyosaki on 20 Years of “Rich Dad Poor Dad”

Also in DBJ

Adventures in Quora with Kevin Price

Privacy Policy